Literature DB >> 22789776

Clinical aspects and outcome of suspected severe pediatric malaria.

J Losimba Likwela1, U D'Alessandro, P Donnen, M Wilmet Dramaix.   

Abstract

OBJECTIVE: The authors had for aim to evaluate diagnosis and treatment practices applied to children with clinically suspected severe malaria, in two referral hospitals of Kisangani. PATIENTS AND METHODS: A prospective study was carried out between January 1, 2010 and February 28, 2011 including all children admitted for clinically suspected severe malaria, with at least one of the WHO severity criteria.
RESULTS: One thousand one hundred and fifty-four children were admitted in the two hospitals, 427 (37.0%, n=1.154) for clinically suspected severe malaria: 155 (36.3%, n=427) had a positive thick drop examination (TDE), 198 (46.4%, n=427) a negative one, and 74 (17.3%, n=427) without thick blood smear examination. Prostration (48.0%) and anemia (40.3%) were the most common severity criteria, while 14.5% and 9.8% presented with convulsions and impaired consciousness respectively. The etiological treatment was quinine infusion. The case specific fatality rate was 19.4% (n=427), 7.7% (n=155) in confirmed cases, 9.6% (n=198) in patients with negative thick blood smear, and 70.3% (n=74) in patients without any TDE (P <0.001).
CONCLUSION: Poor technical support and inadequate organization of the patient circuit can result in underestimating the metabolic complications of severe malaria and of other severe infections of early childhood. This is detrimental to the patients, even when effective drugs are available.
Copyright © 2012. Published by Elsevier SAS.

Entities:  

Mesh:

Year:  2012        PMID: 22789776     DOI: 10.1016/j.medmal.2012.05.008

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  4 in total

1.  Severe malaria and death risk factors among children under 5 years at Jason Sendwe Hospital in Democratic Republic of Congo.

Authors:  Augustin Mulangu Mutombo; Olivier Mukuku; Kristel Nzeba Tshibanda; Edouard Kawawa Swana; Eric Mukomena; Dieudonné Tshikwej Ngwej; Oscar Numbi Luboya; Jean-Baptiste Kakoma; Stanislas Okitotsho Wembonyama; Jean-Pierre Van Geertruyden; Pascal Lutumba
Journal:  Pan Afr Med J       Date:  2018-04-02

2.  Five-Year Status of Malaria (a Disease Causing Anemia) in Yazd, 2008-2012.

Authors:  A Fattahi Bafghi; S A Pourmazar; F Shamsi
Journal:  Iran J Ped Hematol Oncol       Date:  2013-07-22

3.  Methylene blue based device for pathogen reduction in human plasma.

Authors:  A Elikaei; S M Hosseini; Z Sharifi; H Latifi; H Nikbakht; H Mirshafiee; A Asadollahi
Journal:  Iran J Ped Hematol Oncol       Date:  2013-07-22

4.  Feasibility and acceptability of injectable artesunate for the treatment of severe malaria in the Democratic Republic of Congo.

Authors:  Henry M T Ntuku; Gianfrancesco Ferrari; Christian Burri; Antoinette K Tshefu; Didier M Kalemwa; Christian Lengeler
Journal:  Malar J       Date:  2016-01-08       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.